What does this research mean for the field?

Pediatric secondary immune-mediated thrombotic thrombocytopenic purpura (iTTP) frequently presents with severe neurologic involvement and requires early recognition and prompt therapy for favorable outcomes. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

This study aims to describe the clinical features, diagnosis, and treatment of pediatric iTTP.

March 2, 2026Open Access

Case Series and Literature Narrative Review of Immune-Mediated Thrombotic Thrombocytopenic Purpura in Children

View Full Paper

Ask AI

Bookmark

Authors

LRLetiția-Elena RaduCarol Davila University of Medicine and Pharmacy AȘAndreea Nicoleta ȘerbănicăCarol Davila University of Medicine and Pharmacy AMAndra Daniela MarcuCarol Davila University of Medicine and Pharmacy

Discussion

Member takes

Implication

Case series examines pediatric immune-mediated thrombotic thrombocytopenic purpura, suggesting the need for timely diagnosis and treatment.

Key Points

This study aims to describe the clinical features, diagnosis, and treatment of pediatric iTTP.
Conducted a retrospective case series of pediatric iTTP patients.
Reviewed clinical presentations and laboratory findings at a tertiary center.
Performed a literature review of pediatric secondary TTP studies from the last five years.
Four pediatric patients were diagnosed with iTTP, all showing severe thrombocytopenia.
Neurologic symptoms were noted in three out of four cases.
All patients had severe ADAMTS13 activity deficiency with positive inhibitors.
The condition was linked to various autoimmune disorders or had no identifiable trigger.
Early diagnosis was aided by high clinical probability scores and required prompt, directed therapy.

Cite This Study

Radu et al. (2026) studied this question.

synapsesocial.com/papers/69a52e45f1e85e5c73bf1c63 https://doi.org/10.3390/children13030350

View Full Paper

Ask AI

Bookmark

March 2, 2026Open Access

Case Series and Literature Narrative Review of Immune-Mediated Thrombotic Thrombocytopenic Purpura in Children

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Member takes

Implication

Case series examines pediatric immune-mediated thrombotic thrombocytopenic purpura, suggesting the need for timely diagnosis and treatment.

Key Points

This study aims to describe the clinical features, diagnosis, and treatment of pediatric iTTP.
Conducted a retrospective case series of pediatric iTTP patients.
Reviewed clinical presentations and laboratory findings at a tertiary center.
Performed a literature review of pediatric secondary TTP studies from the last five years.
Four pediatric patients were diagnosed with iTTP, all showing severe thrombocytopenia.
Neurologic symptoms were noted in three out of four cases.
All patients had severe ADAMTS13 activity deficiency with positive inhibitors.
The condition was linked to various autoimmune disorders or had no identifiable trigger.
Early diagnosis was aided by high clinical probability scores and required prompt, directed therapy.

Cite This Study

Radu et al. (2026) studied this question.

synapsesocial.com/papers/69a52e45f1e85e5c73bf1c63 https://doi.org/10.3390/children13030350

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark